Loading insider details...
Beta
Latest Form 4 (Mar 25, 2026): Grant/Award of 37,313 DMRA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 25, 2026 | Damora Therapeutics, Inc. (DMRA) | Grant/Award | 37,313 | n/a |
| Feb 12, 2026 | Galecto, Inc. (GLTO) | Exercise/Conversion | 129,000 | n/a |
| Mar 24, 2025 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 3,750 | n/a |
| Mar 18, 2025 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 36,666 | n/a |
| Mar 12, 2025 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 2,399 | n/a |
| Feb 19, 2025 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 650 | n/a |
| Oct 18, 2024 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 18,333 | n/a |
| Jun 24, 2024 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 7,000 | n/a |
| May 24, 2024 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 20,000 | n/a |